GTMS Greenbrook TMS Inc

TORONTO, Oct. 12, 2018 /CNW/ - Bill Leonard, President and CEO, Greenbrook TMS Inc. (GTMS), joined Michael Kousaie, Vice-President, Strategy and Product Innovation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Operating through 43 company-operated treatment centers, Greenbrook TMS Inc. is a provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder (MDD), in the United States. Since opening their flagship Center in McLean, Virginia in 2011, Greenbrook TMS has provided more than 160,000 treatments to over 4,500 patients who were struggling with depression. Greenbrook TMS Inc. commenced trading on Toronto Stock Exchange on October 3, 2018.

SOURCE TMX Group Limited